Policy Update

Italy, Germany, France, and Netherlands sign agreement with British drugmaker for 400 million doses of COVID-19 vaccine in clinical trials

The Inclusive Vaccines Alliance, a group formed by France, Germany, Italy, and the Netherlands, signed a contract with the British drugmaker AstraZeneca to supply up to 400 million doses of COVID-19 vaccine.

The vaccine, developed by the University of Oxford, is still in clinical trials. If the trial results convince regulators the vaccine is safe and effective, deliveries are expected to start by the end of 2020.

The Italian Minister of Health, Roberto Speranza, announced that the vaccine would be distributed for free, starting with the highest-risk groups. Speranza added that a significant part of the production process would take place in Italy.

Press release - Italian Ministry of Health website